These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 5454437
21. Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias. Meyers DG, Mohiuddin SM. Nebr Med J; 1980 May; 65(5):123-5. PubMed ID: 7383223 [No Abstract] [Full Text] [Related]
22. [First experience on the use of disopyramide]. de Oliveira JM. Hospital (Rio J); 1970 Jan; 77(1):35-55. PubMed ID: 5310003 [No Abstract] [Full Text] [Related]
23. Disopyramide: a new agent for effective therapy of ventricular dysrhythmias. Mason DT. Drugs; 1978 May; 15(5):329-30. PubMed ID: 657990 [No Abstract] [Full Text] [Related]
26. [Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine]. Ricciardelli B, Volpe M, De Luca N, D'Ascia C, Bonaduce D, Trimarco B, Rengo F, Condorelli M. Boll Soc Ital Cardiol; 1981 May; 26(2):139-44. PubMed ID: 7337769 [No Abstract] [Full Text] [Related]
27. Examination of the anti-arrhythmic effect of Palpitin (disopyramide). Rohla M, Balázsi I. Ther Hung; 1987 May; 35(4):196-9. PubMed ID: 3447303 [No Abstract] [Full Text] [Related]
31. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias]. Cosnier D, Grimal J, Duchene-Marullaz P. Therapie; 1971 Jul 21; 26(1):97-107. PubMed ID: 5554772 [No Abstract] [Full Text] [Related]
35. [Preliminary clinical observations on the anti-arrhythmic action of a new beta-receptor blocking agent: propranolol]. Cherchi A, Lixi M, Mazza B, Camoglio E. Minerva Med; 1966 Jan 31; 57(9):317-27. PubMed ID: 5909139 [No Abstract] [Full Text] [Related]
37. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients. Aso R, Ohashi K, Katoh T, Ogata H. Int J Clin Pharmacol Res; 2001 Jan 31; 21(3-4):137-46. PubMed ID: 12067143 [Abstract] [Full Text] [Related]
38. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia]. Bracchetti D, Mantovani B, Naccarella F, Lombardi G, Palmieri M. Boll Soc Ital Cardiol; 1980 Jan 31; Suppl():117-23. PubMed ID: 7349604 [No Abstract] [Full Text] [Related]
39. [Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction]. Bassan R, Miqueloti P, de Souza MA, Luz FS. Arq Bras Cardiol; 1982 Nov 31; 39(5):355-7. PubMed ID: 7186390 [No Abstract] [Full Text] [Related]
40. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace). Befeler B, Lazzara R. Heart Lung; 1980 Nov 31; 9(3):475-82. PubMed ID: 6901520 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]